Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pu Youke Phase IV in Acute STEMI
ChiCTR-OIN-16008125Phase 4Completed
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Jun 2012
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant human prourokinase in myocardial infarction (MI), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoints: Clinical opening rate and Coronary patency rate. Started Jun 2012; status: completed.
02
Drugs
recombinant human prourokinase
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-OIN-16008125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16008125.